See more : Kodiak Sciences Inc. (KOD) Income Statement Analysis – Financial Results
Complete financial analysis of Hygrovest Limited (HGV.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hygrovest Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Quebec Precious Metals Corporation (CJCFF) Income Statement Analysis – Financial Results
- Juniper II Corp. (JUN-WT) Income Statement Analysis – Financial Results
- Morgan Stanley (MS-PP) Income Statement Analysis – Financial Results
- American Acquisition Opportunity Inc. (AMAOU) Income Statement Analysis – Financial Results
- Industrial Minerals Ltd (IND.AX) Income Statement Analysis – Financial Results
Hygrovest Limited (HGV.AX)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://hygrovest.com.au
About Hygrovest Limited
Hygrovest Limited operates as a specialist investment company. It focuses on producing capital growth for shareholders over the medium to long term from investments in listed and unlisted securities and other financial assets. The company was formerly known as MMJ Group Holdings Limited and changed its name to Hygrovest Limited in December 2021. Hygrovest Limited was incorporated in 2014 and is headquartered in Sydney, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 260.00K | -9.00K | -16.34M | -70.00K | -41.55M | 33.19M | 211.00K | 76.00K | 255.00K | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 6.00K | 1.00K | 10.00K | 7.00K | 724.00K | 173.00K | 331.00K | 0.00 | 0.00 |
| Gross Profit | 260.00K | -9.00K | -16.34M | -71.00K | -41.56M | 33.18M | -513.00K | -97.00K | -76.00K | 0.00 | 0.00 |
| Gross Profit Ratio | 100.00% | 100.00% | 100.04% | 101.43% | 100.02% | 99.98% | -243.13% | -127.63% | -29.80% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 232.00K | 518.00K | 503.00K | 408.00K | 0.00 |
| General & Administrative | 928.00K | 1.38M | 1.22M | 1.28M | 1.12M | 1.87M | 13.64M | 5.34M | 4.62M | 2.16M | 0.00 |
| Selling & Marketing | 175.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 509.00K | 638.00K | 453.00K | 150.55K | 0.00 |
| SG&A | 1.10M | 1.38M | 1.22M | 1.28M | 1.12M | 1.87M | 14.15M | 5.98M | 5.07M | 4.85M | 0.00 |
| Other Expenses | 0.00 | -2.77M | -16.99M | -5.97M | -42.10M | 33.51M | 48.28M | -2.28M | -19.00K | 0.00 | 0.00 |
| Operating Expenses | 260.00K | 1.58M | 1.46M | 1.62M | 1.65M | 2.73M | 14.38M | 9.86M | 6.50M | 5.37M | 0.00 |
| Cost & Expenses | 1.10M | 1.58M | 1.46M | 1.62M | 1.65M | 2.73M | 15.10M | 10.03M | 6.83M | 5.37M | 0.00 |
| Interest Income | 206.00K | 187.00K | 657.00K | 789.00K | 843.00K | 129.00K | 225.00K | 46.00K | 37.00K | 46.91K | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.49M | 82.00K | 56.00K | 0.00 | 0.00 |
| Depreciation & Amortization | 259.00K | 6.00K | 6.00K | 1.00K | 10.00K | 7.00K | 709.00K | 1.10M | 68.00K | 5.26M | 0.00 |
| EBITDA | -844.00K | -1.58M | -17.79M | -6.80M | -42.89M | 30.92M | 3.86M | -12.96M | -14.58M | -66.55K | 0.00 |
| EBITDA Ratio | -324.62% | 17,555.56% | 8.92% | 2,307.14% | 3.94% | -8.20% | 16,296.68% | -14,584.21% | -2,545.10% | 0.00% | 0.00% |
| Operating Income | -1.10M | -1.58M | -1.46M | -1.62M | -1.65M | -2.73M | 33.68M | -12.19M | -6.56M | -5.26M | 0.00 |
| Operating Income Ratio | -424.23% | 17,555.56% | 8.96% | 2,308.57% | 3.96% | -8.22% | 15,960.66% | -16,032.89% | -2,571.76% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.20M | -2.58M | -16.34M | -5.18M | -41.26M | 33.64M | 17.51M | -2.12M | -8.14M | -66.55K | 0.00 |
| Income Before Tax | 95.00K | -4.16M | -17.80M | -6.80M | -42.90M | 30.91M | 31.97M | -12.27M | -14.70M | -5.33M | 0.00 |
| Income Before Tax Ratio | 36.54% | 46,255.56% | 108.92% | 9,712.86% | 103.27% | 93.15% | 15,151.66% | -16,140.79% | -5,764.31% | 0.00% | 0.00% |
| Income Tax Expense | 226.00K | -179.00K | -1.86M | -2.78M | -2.82M | 9.29M | 2.96M | -3.95M | 37.00K | -66.55K | 0.00 |
| Net Income | -131.00K | -3.98M | -15.93M | -4.02M | -40.08M | 21.62M | 29.01M | -10.51M | -14.70M | -5.33M | 0.00 |
| Net Income Ratio | -50.38% | 44,266.67% | 97.52% | 5,748.57% | 96.48% | 65.14% | 13,746.92% | -13,827.63% | -5,764.31% | 0.00% | 0.00% |
| EPS | 0.00 | -0.02 | -0.07 | -0.02 | -0.18 | 0.09 | 0.14 | -0.06 | -0.11 | -0.18 | 0.00 |
| EPS Diluted | 0.00 | -0.02 | -0.07 | -0.02 | -0.18 | 0.09 | 0.13 | -0.06 | -0.11 | -0.18 | 0.00 |
| Weighted Avg Shares Out | 210.31M | 229.47M | 229.95M | 229.95M | 226.42M | 230.05M | 214.60M | 189.67M | 137.76M | 29.92M | 34.46M |
| Weighted Avg Shares Out (Dil) | 210.31M | 229.47M | 229.95M | 229.95M | 226.42M | 230.05M | 223.65M | 189.69M | 137.78M | 29.92M | 34.46M |
Source: https://incomestatements.info
Category: Stock Reports